EBEsther Burden-Teh

Esther Burden-Teh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Esther Burden-Teh has a total of 223 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Can Systemic Treatment for Childhood Psoriasis Be Stopped in Cases of Remission? Data From the ACMe Cohort

    by Ahmad Rached, Yuyun Miao, Alain Beauchet, Maryam Piram, Tess McPherson, Tiago Torres, Yasmine Yesli, Hélène Aubert, Christine Bodemer, Cristina Bertoli, et al.

    Background: In childhood, moderate‐to‐severe psoriasis often requires systemic treatments such as acitretin, methotrexate, or cyclosporine. This study aimed to explore the feasibility of discontinuing systemic therapy in pediatric patients who achieve remission when receiving these treatments and to identify predictors of sustained remission. Methods: The ACMe cohort study was a retrospective, multicenter, international, real‐world study involving children and adolescents with moderate‐to‐severe psoriasis treated with acitretin, methotrexate, or cyclosporine. Patients who achieved remission and stopped their systemic treatment were monitored for up to 6 months to evaluate the need for further systemic treatment. Results: Of the 433 patients analyzed, 79 (18.2%) discontinued systemic treatment due to remission. Of these, 70 (88.6%) remained off systemic treatment for at least 6 months. Factors predictive of discontinuation due to remission included younger age (9.0 ± 3.5 vs. 10.5 ± 4.1 years, p < 0.001); lower baseline psoriasis severity (PGA: 3.0 ± 0.7 vs. 3.3 ± 0.8; and PASI: 9.3 ± 4.8 vs. 11.1 ± 6.8, p < 0.04); and the presence of non‐palmoplantar forms of psoriasis (palmoplantar psoriasis : 5 (6.3%) vs. 58 (16.4%), p = 0.02). No factors were identified that predicted sustained remission at 6 months. Conclusions: These promising results suggest that systemic treatment discontinuation during clinical remission is feasible for pediatric patients with moderate‐to‐severe psoriasis and is associated with a low risk of early relapse. Prospective studies with long‐term follow‐up are needed to confirm the durability of remission and to better define criteria for selecting candidates for treatment discontinuation.

  • Open Access

    Spironolactone for the treatment of acne vulgaris affecting female patients aged ≤ 18 years: results from a UK and Irish Survey of healthcare professionals

    by Zahra Moledina, Lisa O’HIggins, Myranda Attard, Julia Fordham, Grishma Ramesh, Fiona Sexton, Lydia Tutt, Alison Layton, Miriam Santer, Jane Ravenscroft, et al.

    A survey of UK and Irish healthcare professionals was distributed via the UK Dermatology Clinical Trials Network, British Society for Paediatric and Adolescent Dermatologists, Irish Association of Dermatologists and other regional groups. The aim was to understand how healthcare professionals prescribe spironolactone for female patients, with a particular focus on those aged ≤ 18 years, as well as concerns regarding side effects and thoughts about a future clinical trial. A total of 116 responses were received from healthcare professionals, including dermatologists, dermatology nurses, paediatricians, general practitioners and pharmacists. The results showed that there is varied clinical practice and confidence among healthcare professionals treating this population with spironolactone, with the main safety concerns being around hormonal implications, future pregnancies and lack of long-term data.

  • Open Access

    Teleconsultations for Eczema in CHildren (TECH) feasibility study: a mixed-methods study with adolescents and parents

    by Natalie King Stokes, Aoife Daly, Sarah McCusker, Manrup Hunjan, Ellen Vincent, Ashima Lowe, Carolyn Charman, Jonathan Mathers, Lea Solman, Susannah George, et al.

    Background: Teleconsultations form a key component of the National Health Service’s Long Term Plan, outpatient recovery and ­transformation, and commitment to net zero. There is currently little evidence to inform their delivery within paediatric dermatology, a specialty that is increasingly difficult to access. Teleconsultations may offer convenience and widen access for patients, particularly for follow-up of chronic conditions such as eczema. Objectives: To explore patients’ and parents’ experiences and perceptions of teleconsultations for follow-up of eczema in secondary or tertiary care; to identify components of acceptability of different consultation types and explore how teleconsultations could be optimized; and to obtain views of a potential trial comparing face-to-face appointments with teleconsultations for paediatric eczema follow-up. Methods: A mixed-methods study comprising an online survey and qualitative interviews with patients and parents of children with eczema, who had experience of teleconsultations under secondary or tertiary care, was carried out. An online survey was completed by eligible adolescents and parents. The results informed subsequent semi-structured interviews, conducted with patients and parents, and responses were analysed thematically using framework analysis. Results: Survey responses from 31 parents and 20 adolescents were analysed. Overall, 41% were ‘satisfied or very satisfied’ following telephone appointments vs. 71% for video and 40% for online or mobile messaging. Preferred consultation type was face-to-face in 67%, with 31% preferring a combination of face-to-face and teleconsultations. Some 41% of participants were interested in participating in a trial comparing face-to-face and teleconsultations for eczema follow-up. Qualitative interviews were conducted with 10 parents and 2 adolescents. Six overarching themes were constructed from the interview data: the value of a dermatology appointment, what is important in an eczema consultation, concerns about patient assessment, complexity of acceptability, patient choice and optimizing teleconsultations. Conclusions: While there was a preference for face-to-face consultations, teleconsultations were acceptable in certain situations, such as for stable eczema or to avoid missing school. Patient perspectives of how teleconsultations could be improved include sending photographs before the appointment and clinician training. This study suggests that directly comparing face-to-face appointments with teleconsultations in a future trial is unlikely to be feasible. A hybrid intervention combining face-to-face and teleconsultation would be more acceptable to patients and parents.

  • Open Access

    Fraudulent responses in online survey research in dermatology: are your participants who you think they are?

    by Natalie King Stokes, Sarah McCusker, Aoife Daly, Manrup Hunjan, Ashima Lowe, Carolyn Charman, Lea Solman, Susannah George, Esther Burden-Teh

    Surveys are a commonly used research method in dermatology. The use of online surveys has increased over the past decade, as has the use of social media to recruit potential participants. There is a growing risk of fraudulent or bot responses to online surveys. Such responses threaten data integrity and waste researcher time and funding. We report our experience of conducting an online survey investigating the experiences of adolescents and parents having teleconsultations for paediatric eczema. We experienced a rapid influx of responses within 24 h, of which almost all appeared to be fraudulent. Indicators of fraudulent responses included duplicate free-text responses and clusters of surveys that were started and completed in tandem. Dermatological researchers should be aware of this issue and incorporate a plan to prevent, identify and manage fraudulent responses into the study protocol.


  • Paediatric dermatology teleconsultations: a survey of healthcare professionals in the UK

    by Sarah McCusker, Natalie King Stokes, Manrup Hunjan, Aoife Daly, Susannah George, Lea Solman, Esther Burden-Teh

    The Covid-19 pandemic catapulted dermatology services into a digital era, with the rapid introduction of teleconsultations. The National Health Service (NHS) operational planning guidance recommends ≥25% of consultations are delivered remotely.1 There is a lack of data regarding acceptability and effectiveness of paediatric dermatology teleconsultations. We surveyed UK health care professionals (HCP) to explore their experiences of teleconsultations in paediatric dermatology, with a focus on follow-up consultations for paediatric eczema (PE), to inform a future clinical trial. There were 119 responses. Pre-pandemic, 37% provided some form of teleconsultation service, rising to 93% post-pandemic. Forty-one percent (n=49) now carry out >25% of consultations remotely. Fifty-five percent felt teleconsultations were less effective than face-to-face for PE follow-up. Eighty HCP offered teleconsultations for PE. The most effective format for PE follow-up was felt to be telephone with photographs (n=52, 65%). Our results demonstrate varying opinion on the effectiveness and optimal format of paediatric teleconsultations, supporting the need for further research.


  • Open Access

    Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated

    by Edmond Atallah, Jane I. Grove, Colin Crooks, Esther Burden-Teh, Abhishek Abhishek, Sulleman Moreea, Kelsey M. Jordan, Aftab Ala, David Hutchinson, Richard J. Aspinall, et al.


  • Open Access

    Where are we with developing diagnostic criteria for skin diseases? Mapping the evidence in 2021

    by Jessie Luke, Esther Burden-Teh

    The breadth and scope of dermatological diagnostic criteria is currently unknown. We created a map of diagnostic criteria to provide a panoramic view of past and ongoing research to develop dermatological diagnostic criteria. We analysed studies for which the primary research aim was to develop, validate or critically appraise diagnostic criteria for dermatological conditions identified with a PubMed search conducted in July 2021. The researched skin diseases were grouped based on similarities in pathogenesis. In total, 166 studies covering 104 skin diseases were included in the data extraction. The two largest disease categories were autoimmune diseases (17%) and rare disorders and genetic syndromes (17%). Of the total studies analysed, 28% included a type of validation and 64% provided diagnostic accuracy data. This map of diagnostic criteria covers a vast range of dermatological conditions, but many common skin diseases were under-represented. We plan to update the map and make it available for all health professionals and researchers.

  • Open Access

    How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals

    by Zahra Moledina, Margaret McPhee, Jane C Ravenscroft, Eugene Healy, Kathy Radley, Kim S Thomas, Esther Burden-Teh, Acne-ID Trial Development Team, Trish Hepburn, Carron Layfield, et al.

    We undertook a survey of UK healthcare professionals through the UK Dermatology Clinical Trials Network and British Dermatological Nursing Group to understand clinicians’ routine practice of prescribing oral isotretinoin for treatment of acne vulgaris. We also wanted to understand clinicians’ experiences and views on prescribing low daily dose regimens. Overall, the survey showed that clinicians adopted a patient-centred approach when deciding isotretinoin dosing. The rationale for using a low-dose regimen varied, but was focused on patient wellbeing during treatment. Some clinicians were concerned that use of a low-dose regimen could be less effective and lead to longer treatment durations. The survey results will be useful to inform a clinical trial investigating the effectiveness and safety of low daily dose isotretinoin for the treatment of acne.


  • Open Access

    On the definition of dermatological disease. Part 2: approaches for defining dermatological diseases

    by Hywel C. Williams, Esther Burden-Teh

    Summary: In Part 1 of this two-part review, conceptual frameworks for defining skin diseases were articulated. In this review, the main approaches that can be used to develop diagnostic criteria for skin disease are summarized, using atopic dermatitis (AD) as an example. Different frameworks for defining skin disease for research purposes are articulated, including statistical, prognostic, operational, clinical and epidemiological approaches. All share the common aim of attempting to develop criteria that enable meaningful comparisons between groups of people. The desirable attributes of a good definition are described: diagnostic criteria should measure what they are meant to measure; the results should be the same for different assessors; the criteria should be coherent with what is known about that disease; they should reflect some degree of morbidity and not pick up subclinical disease; they should be easy to administer; and they should be applicable to a range of people of different ages, sexes/genders and ethnicities. Consensus-based criteria are contrasted with epidemiological derivation methods that assess the performance of diagnostic criteria in relation to a reference standard. The sensitivity and specificity of a disease definition is explained, along with how the trade-off between these two properties can vary, depending on the purpose of the study and the study setting. The review closes with some reflections on when it is appropriate to consider splitting a disease into more than one category and how diagnostic criteria can be interpreted in the clinical setting.


  • Open Access

    Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case–control diagnostic accuracy study (DIPSOC study)*

    by E. Burden‐Teh, R. Murphy, S. Gran, T. Nijsten, C. Hughes, A. Abdul‐Wahab, A. Bewley, N. Burrows, S. Darne, J.E. Gach, et al.

    Background In children, psoriasis can be challenging to diagnose. Difficulties arise from differences in the clinical presentation compared to adults. Objectives To test the diagnostic accuracy of previously agreed consensus criteria and develop a shortlist of best predictive diagnostic criteria for childhood psoriasis. Methods A case-control diagnostic accuracy study in 12 UK dermatology departments (2017-2019) assessed 18 clinical criteria using blinded trained investigators. Children (<18 years) with dermatologist diagnosed psoriasis (cases n=160) or a different scaly inflammatory rash (controls n=170) were recruited. The best predictive criteria were identified using backward logistic regression and internal validation was conducted using bootstrapping. Results The sensitivity of the consensus agreed criteria and consensus scoring algorithm was 84.4%, specificity was 65.1% and area under the curve (AUC) 0.75. Seven diagnostic criteria which performed best were: i) scale and erythema in the scalp involving the hairline; ii) scaly erythema inside the external auditory meatus; iii) persistent well-demarcated erythematous rash anywhere on the body; iv) scaly erythematous plaques on the extensor surfaces of the elbows and/or knees; v) persistent erythema in the umbilicus; vi) well demarcated erythematous rash in the napkin area involving the crural folds; vii) family history of psoriasis. Sensitivity of the best predictive model was 76.8%, specificity 72.7% and AUC 0.84. The c-statistic optimism adjusted shrinkage factor was 0.012. Conclusions This study provides examination and history-based data on the clinical features of psoriasis in children and proposes seven diagnostic criteria with good discriminatory ability in secondary care patients. External validation is now needed.